Clinical Trials Browser

Phase 2 × Withdrawn × veliparib × Clear all

NCT03044795 2024-05-03

REPAIR

Phase 2 Withdrawn

Neoplasms

NCT03032614 2017-10-10

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients

Phase 2 Withdrawn

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms